Released Mar 16, 2016, after the close
10-Q filed Mar 16, 2016, 45 days after period end · 0001354488-16-006612
Q1 2016 · 10-Q
Revenue—
Net Income$350.01K$350.01K +21.4% vs Q1 2015−33.1% vs Q4 2015
EPS Diluted$0.02$0.02 +25.0% vs Q1 2015no prior Q4 2015 on file
Gross Profit$1,758,391+3.1%
Operating Income$384,148+17.0%
Operating Cash Flow$72,322−38.5%
Free Cash Flowderived-$342,042N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | $350.01K | $288.39K | $661.93K | $1.05M |
| EPS Diluted | $0.02 | $0.01 | $0.03 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR